The use of lithium to augment antidepressant medication

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL. 5, 1998, Pages 32-41

  Rouillon, F ^a   Gorwood, Philip ^a  

^a HÔPITAL LOUIS MOURIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADINAZOLAM MESILATE; ALPRAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; BUSPIRONE; CARBAMAZEPINE; CLOMIPRAMINE; DESIPRAMINE; DEXAMETHASONE; DOXEPIN; FLUOXETINE; FLUVOXAMINE MALEATE; IMIPRAMINE; IPRINDOLE; ISOCARBOXAZID; LITHIUM; TRIMIPRAMINE;

AMNESIA; ARTICLE; ATAXIA; CONFUSION; DATA ANALYSIS; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; HUMAN; HYPERTHERMIA; MYOCLONUS; PRIORITY JOURNAL; PROPHYLAXIS; TREMOR;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CLINICAL TRIALS; DEPRESSIVE DISORDER; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0031840691     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (93)

1. Schou M. Lithium in psychiatric therapy and prophylaxis. J Psychiatr Res 1968;6:67-95
2. Gershon S. Lithium in mania. Clin Pharmacol Ther 1970;11:168-187
3. Prien RF, Caffey EM, Klett CJ. Relationship between serum lithium level and clinical response in acute mania treated with lithium. Br J Psychiatry 1972;120:409-414
4. Baastrup PC, Poulsen JC, Schou M, et al. Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 1970;2:326-330
5. Angst J, Weiss P, Grof P, et al. Lithium prophylaxis in recurrent affective disorders. Br J Psychiatry 1970;116:604-614
6. Worrall EP, Moody JP, Peet M, et al. Controlled studies of the acute antidepressant effect of lithium. Br J Psychiatry 1979;135:255-262
7. Zall H, Therman PG, Myers JM. Lithium carbonate: a clinical study. Am J Psychiatry 1968;125:549-555
8. Himmelhoch JM, Detre T, Kupfer DJ, et al. Treatment of previously intractable depressions with tranylcypromine and lithium. J Nerv Ment Dis 1972; 155:216-220
9. O'Flanagan P. Clomipramine infusion and lithium carbonate: a synergistic effect? [letter] Lancet 1973;2:974
10. de Montigny C, Aghajanian GK. Tricyclic antidepressants: long term treatment increases responsivity of rat forebrain neurons to serotonin. Science 1978;202:1303-1306
11. de Montigny C, Grunberg F, Mayer A, et al. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry 1981;138:252-256
12. Katona CLE. Lithium augmentation in refractory depression. Psychiatric Developments 1988;2:153-171
13. Schöpf J. Treatment of depressions resistant to tricyclic antidepressants related drugs or MAO inhibitors by lithium addition: review of literature. Pharmacopsychiatry 1989;22:174-182
14. Schou M. Lithium and treatment resistant depression: a review. Lithium 1990;1:3-8
15. de Montigny C. Lithium addition in treatment-resistant depression. Int Clin Psychopharmacol 1994;9:31-35
16. Austin MPV, Souza FGM, Goodwin GM. Lithium augmentation in antidepressant-resistant patients: a quantitative analysis. Br J Psychiatry 1991; 159:510-514
17. Flint A. Lithium augmentation in antidepressant resistant patients [letter]. Br J Psychiatry 1992;160:710
18. Patten SB, Lupin DA, Boucher SA, et al. Pharmacologic management of refractory depression. Can Med Assoc J 1992;146:483-487
19. Katona CLE. Refractory depression: a review with particular reference to the use of lithium augmentation. Eur Neuropsychopharmacol 1995;5 (suppl):109-113
20. Nelson JC, Byck R. Rapid response to lithium in phenelzine non-responders. Br J Psychiatry 1982;141:85-86
21. Birkhimer LJ, Alderman AA, Schmitt CE, et al. Combined trazodone-lithium therapy for refractory depression. Am J Psychiatry 1983;140: 1382-1383
22. Joyce PR, Hewland HR, Jones AV. Rapid response to lithium in treatment resistant depression. Br J Psychiatry 1983;142:204-206
23. Weaver KEC. Lithium for delusional depression. Am J Psychiatry 1983; 140:962-963
24. Schrader GD, Levien HEM. Response to sequential administration of clomipramine and lithium carbonate in treatment resistant depression. Br J Psychiatry 1985;147:573-575
25. Pande AD, Max P. A lithium-tricyclic combination for treatment of depression. Am J Psychiatry 1985;142:1228-1229
26. Roy A, Pickar D. Lithium potentiation of imipramine in treatment resistant depression. Br J Psychiatry 1985;147:582-583
27. Madakasira S. Low dose potency of lithium in antidepressant augmentation. Psychiatric Journal of the University of Ottawa 1986;11:107-109
28. Pai M, White AC, Deane AG. Lithium augmentation in the treatment of delusional depression. Br J Psychiatry 1986;148:736-738
29. 3 potentiation. Am J Psychiatry 1986; 143:1038-1039
30. Delisle JD. Rapid switch in a bipolar patient during lithium tricyclic therapy. Am J Psychiatry 1986;143:1326-1327
31. Kushnir SL. Lithium-antidepressant combinations in the treatment of depressed, physically ill geriatric patients. Am J Psychiatry 1986;143: 378-379
32. Tariot PN, Murphy DL, Sunderland T, et al. Rapid antidepressant effect of addition of lithium to tranylcypromine. J Clin Psychopharmacol 1986;6: 165-167
33. Cerra D, Meacham T, Coleman J. A possible synergistic effect of alprazolam and lithium carbonate [letter]. Am J Psychiatry 1986;143:552
34. Lieff S, Herrmann N. Combined drug therapy for an elderly depressed patient [letter]. Am J Psychiatry 1988;145:1034-1035
35. Manning JS, Connor PD. Antidepressant augmentation with lithium. J Fam Pract 1994;39:379-383
36. Fein S, Paz V, Rao N, et al. The combination of lithium carbonate and an MAOI in refractory depressions. Am J Psychiatry 1988;145:249-250
37. Yuvarajan R, Yousufzai NM. Mania induced by lithium augmentation: a case report. Br J Psychiatry 1988;153:828-830
38. Conte G. Lithium, imipramine and hydroxytryptophan in resistant depression [letter]. Br J Psychiatry 1988;152:720
39. Feder R. Lithium augmentation of clomipramine [letter]. J Clin Psychiatry 1988;49:458
40. Pope HG, McElroy SL, Nixon RA. Possible synergism between fluoxetine and lithium in refractory depression. Am J Psychiatry 1988;145: 1292-1294
41. Price LH, Delgado PL, Charney DS, et al. Sequence of drug administration in lithium augmentation: a case study. J Clin Psychiatry 1988;49:161-162
42. Rasmussen SA. Lithium and tryptophan augmentation in clomipramine resistant obsessive-compulsive disorder. Am J Psychiatry 1984;141: 1283-1285
43. Cournoyer G. Rapid response of a disorder to the addition of lithium carbonate: panic resistant to tricyclic antidepressants. Can J Psychiatry 1986; 31:335-338
44. Howland RH. Lithium augmentation of fluoxetine in the treatment of OCD and major depression: a case report. Can J Psychiatry 1991;36:154-155
45. Neubauer H, Bermingham P. A depressive syndrome responsive to lithium: an analysis of 20 cases. J Nerv Ment Dis 1976;163:276-281
46. de Montigny C, Cournoyer G, Morissette R, et al. Lithium carbonate addition in tricyclic antidepressant resistant unipolar depression: correlations with the neurobiologie actions of tricyclic antidepressant drugs and lithium ion on the serotonin system. Arch Gen Psychiatry 1983;40:1327-1334
47. Price LH, Conwell Y, Nelson JC. Lithium augmentation of combined neuroleptic tricyclic treatment in delusional depression. Am J Psychiatry 1983; 140:318-322
48. Heninger GR, Charney DS, Sternberg DE. Lithium carbonate augmentation of antidepressant treatment: an effective prescription for treatment refractory depression. Arch Gen Psychiatry 1983;40:1335-1342
49. Alvarez E, Udina C, Queralto JM, et al. Factors indicating the favourable response of lithium added to the treatment of resistant depression [abstract]. Collegium International of Neuro-psychopharmacology 1984;14: 75
50. Bellwald J. Lithium/Antidepressiva-Kombinations-Therapie bei endogenen Depressionen. Inaugural Dissertation [abstract]. Zurich, Switzerland: University of Zurich; 1984
51. Louie AK, Meltzer HY. Lithium augmentation of antidepressant treatment. J Clin Psychopharmacol 1984;4:316-321
52. de Montigny C, Elie R, Gaille G. Rapid response to the addition of lithium in iprindole-resistant unipolar depression: a pilot study. Am J Psychiatry 1985;142:220-223
53. Joyce PR. Mood response to methylphenidate and the dexamethasone suppression test as predictors of treatment response to zimelidine and lithium in major depression. Biol Psychiatry 1985;20:598-604
54. Price LH, Charney DS, Heninger GR. Variability of response to lithium augmentation in refractory depression. Am J Psychiatry 1986;143: 1387-1392
55. Charney DS, Price LH, Heninger GR. Desipramine-yohimbine combination treatment of refractory depression: implications for the β-adrenergic receptor hypothesis of antidepressant action. Arch Gen Psychiatry 1986; 43:1155-1161
56. Nelson JC, Mazure CM. Lithium augmentation in psychotic depression refractory to combined drug treatment. Am J Psychiatry 1986;143:363-366
57. Hale AS, Procter AW, Bridges PK. Clomipramine, tryptophan and lithium combination for resistant endogenous depression: seven case studies. Br J Psychiatry 1987;151:213-217
58. Delgado PL, Price LH, Charney DS, et al. Efficacy of fluvoxamine in treatment refractory depression. J Affect Disord 1988;15:55-60
59. Ryan ND, Meyer V, Dachille S, et al. Lithium antidepressant augmentation in TCA refractory depression in adolescents. J Am Acad Child Adolesc Psychiatry 1988;145:1317-1318
60. Cohen LS, Heller VL, Rosenbaum JF, et al. Adjuvant lithium carbonate in refractory depression. In: New Research Program and Abstracts of the 141st Annual Meeting of the American Psychiatric Association; May 1988
61. Thase ME, Kupfer DJ, Frank E, et al. Treatment of imipramine-resistant recurrent depression, II: an open clinical trial of lithium augmentation. J Clin Psychiatry 1989;50:413-417
62. Fontaine R, Ontiveros A, Elie R, et al. Lithium carbonate augmentation of desipramine and fluoxetine in refractory depression. Biol Psychiatry 1991; 29:946-948
63. Rybakowski J, Matkowski K. Adding lithium to antidepressant therapy: factors related to therapeutic potentiation. Eur Neuropsychopharmacol 1992;2:161-165
64. McCance-Katz E, Price LH, Charney DS, et al. Serotoninergic function during lithium augmentation of refractory depression. Psychopharmacology(Berl) 1992;108:93-97
65. Honore P, Moller SE, Jorgensen A. Lithium + L-tryptophan compared with amitriptyline in endogenous depression. J Affect Disord 1982;4:79-82
66. 3 and lithium potentiation to tricyclic antidepressants [letter]. Am J Psychiatry 1988;145:1317-1318
67. Thase ME, Kupfer DJ, Jarrett DB. Treatment of imipramine-resistant recurrent depression, I: an open clinical trial of adjunctive L-triiodothyronine. J Clin Psychiatry 1989;50:385-388
68. Dinan TG, Barry S. A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatr Scand 1989:80:97-100
69. Zall H. Lithium carbonate and isocarboxazid: an effective drug approach in severe depression. Am J Psychiatry 1971;127:1400-1403
70. Lingjaerde O, Edlund AH, Gormsen CA, et al. The effect of lithium carbonate in combination with tricyclic antidepressants in endogenous depression. Acta Psychiatr Scand 1974;50:233-242
71. Nick J, Luaute JP, Des Lauriers A, et al. L'association clomipramine lithium: essai contrôlé. L'Encéphale 1976;2:5-16
72. Price LH, Charney DS, Heninger GR. Efficacy of lithium tranylcypromine treatment in refractory depression. Am J Psychiatry 1985;142:619-623
73. Ebert D, Jasper A, Murata H, et al. Initial lithium augmentation improves the antidepressant effects of standard TCA treatment in non resistant depressed patients. Psychopharmacology 1995;118:223-225
74. Cournoyer G, de Montigny C, Ouellette J, et al. Lithium addition in tricyclic resistant unipolar depression: a placebo controlled study. Collegium International of Neuro-Psychopharmacology 1984;14:F17
75. Kantor D, McNevin S, Leichner P, et al. The benefit of lithium carbonate adjunct in refractory depression: fact or fiction? Can J Psychiatry 1986;31: 416-418
76. Zusky PM, Biederman J, Rosenbaum JF, et al. Adjunct low dose lithium carbonate in treatment resistant depression: a placebo controlled study. J Clin Psychopharmacol 1988;8:120-124
77. Schöpf J, Baumann P, Lemarchand T, et al. Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition. Pharmacopsychiatry 1989;22:183-187
78. Kramlinger KG, Post R. The addition of lithium to carbamazepine: antidepressant efficacy in treatment-resistant depression. Arch Gen Psychiatry 1989;46:794-800
79. Stein G, Bernadt M. Lithium augmentation therapy in tricyclic-resistant depression: a controlled trial using lithium in low and normal doses. Br J Psychiatry 1993;162:634-640
80. Katona CLE, Abou-Saleh MT, Harrison DA, et al. Placebo controlled trial of lithium augmentation of fluoxetine and lofepramine. Br J Psychiatry 1995;166:80-86
81. Price LH, Charney DS, Heninger GR. Manic symptoms following addition of lithium to antidepressant treatment. J Clin Psychopharmacol 1984;4: 361-362
82. Khan MC, Wickham EA, Reed JV. Lithium versus placebo in acute depression: a clinical trial. Int Clin Psychopharmacol 1987;2:47-54
83. Nierenberg AA, Price LH, Charney DS, et al. After lithium augmentation: a retrospective follow-up of patients with antidepressant refractory depression. J Affect Disord 1990;18:167-175
84. Austin LS, Arana GW, Melvin JA. Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients. J Clin Psychiatry 1990;51:344-345
85. Solomon JG. Seizures during lithium amitriptyline therapy. Postgrad Med 1979;163:276-281
86. Mahapatra RK, Paul SK, Mahapatra D, et al. Cardiovascular effects of polycyclic antidepressants. Angiology 1986;37:709-717
87. Devanand DP, Sacheim HA, Brown RP. Myoclonus during combined tricyclic antidepressant and lithium treatment. J Clin Psychopharmacol 1988;8: 446-447
88. Salama AA, Shafey M. A case of severe lithium toxicity induced by combined fluoxetine and lithium carbonate [letter]. Am J Psychiatry 1989;146: 278
89. Sacristan JA, Iglesias C, Arellano F, et al. Absence seizures induced by lithium: possible interaction with fluoxetine. Am J Psychiatry 1991;148 146-147
90. Evans M, Marwick P. Fluvoxamine and lithium: an unusual interaction [letter]. Br J Psychiatry 1990;156:286
91. Hadley A, Cason MP. Mania resulting from lithium fluoxetine combination [letter]. Am J Psychiatry 1989;146:1637-1638
92. Grahame-Smith DG, Green AR. The role of brain 5 hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxydase inhibition. Br J Pharmacology 1974;52:19-26
93. Broderick P, Lynch V. Behavioural and biochemical changes induced by lithium and L-tryptophan in muricidal rats. Neuropharmacology 1982;21: 671-679